Chapter 12: Schizophrenia Spectrum Disorders
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
The spectrum includes distinct diagnoses such as delusional disorder, brief psychotic disorder, schizophreniform disorder, and schizoaffective disorder, all of which must be differentiated from substance-induced or medically caused psychosis. Schizophrenia itself typically progresses through predictable prodromal, acute, stabilization, and maintenance phases. The clinical picture is defined by four major symptom clusters: positive symptoms (the presence of abnormal phenomena, like delusions, hallucinations, and disorganized speech such as associative looseness or clang associations); negative symptoms (deficits in normal function, including avolition, anhedonia, and alogia); cognitive symptoms (deficits in memory, attention, and executive functioning, often resulting in concrete thinking); and affective symptoms (mood instability and depression). Etiology is complex, involving inherited genetic factors and environmental stressors, alongside significant neurobiological findings such as altered dopamine, serotonin, and glutamate neurotransmission, and structural brain abnormalities like reduced gray matter. Nursing care emphasizes assessment for safety risks (paranoia, command hallucinations, suicide) and addressing comorbidities like substance use and physical illnesses. Pharmacological treatment utilizes first-generation antipsychotics (FGAs), highly effective against positive symptoms, and second-generation antipsychotics (SGAs), which also help negative symptoms and carry a lower risk of extrapyramidal side effects (EPS). Nurses must vigilantly monitor for serious adverse reactions, including acute dystonia, pseudoparkinsonism, persistent tardive dyskinesia, life-threatening neuroleptic malignant syndrome (NMS), anticholinergic toxicity, and metabolic syndrome (weight gain, dyslipidemia). Crucial nursing interventions include reality testing, using concrete communication for patients with cognitive deficits, promoting treatment adherence, and recognizing and managing anosognosia (the lack of awareness of one’s own illness).